AMV Stock Overview
Engages in the manufacturing and trading of medical diagnostic biological products in Vietnam. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
American Vietnamese Biotech Incorporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫1,500.00 |
| 52 Week High | ₫4,300.00 |
| 52 Week Low | ₫1,400.00 |
| Beta | 1.45 |
| 1 Month Change | 0% |
| 3 Month Change | -28.57% |
| 1 Year Change | -60.53% |
| 3 Year Change | -86.24% |
| 5 Year Change | -88.83% |
| Change since IPO | -82.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMV | VN Medical Equipment | VN Market | |
|---|---|---|---|
| 7D | 7.1% | 1.6% | 1.2% |
| 1Y | -60.5% | -0.4% | 4.9% |
Return vs Industry: AMV underperformed the VN Medical Equipment industry which returned -0.4% over the past year.
Return vs Market: AMV underperformed the VN Market which returned 4.9% over the past year.
Price Volatility
| AMV volatility | |
|---|---|
| AMV Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in VN Market | 7.3% |
| 10% least volatile stocks in VN Market | 2.1% |
Stable Share Price: AMV's share price has been volatile over the past 3 months compared to the VN market.
Volatility Over Time: Insufficient data to determine AMV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | www.amvibiotech.com |
American Vietnamese Biotech Incorporation engages in the manufacturing and trading of medical diagnostic biological products in Vietnam. The company develops centralized testing centers; and provides medical machinery and equipment, and testing chemicals. It also offers sterilizers, drug labeling machines, medical image disc recorders, medical dry films, medical dry film printers, and digital radiology systems; lizer infrared therapy machines; infusion pumps and electric injection pumps; automatic molecular biology testing machines and automatic immunoassay machines and chemicals; medical equipment, x-ray systems, mobile x-ray systems, portable c-arm x-ray systems, 3T and 1.5 T systems, portable color ultrasound systems, and CT scan systems; endoscopic wire washing machines; and medical software products.
American Vietnamese Biotech Incorporation Fundamentals Summary
| AMV fundamental statistics | |
|---|---|
| Market cap | ₫196.66b |
| Earnings (TTM) | -₫59.04b |
| Revenue (TTM) | ₫132.48b |
1.5x
P/S Ratio-3.3x
P/E RatioIs AMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMV income statement (TTM) | |
|---|---|
| Revenue | ₫132.48b |
| Cost of Revenue | ₫117.34b |
| Gross Profit | ₫15.13b |
| Other Expenses | ₫74.17b |
| Earnings | -₫59.04b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -450.31 |
| Gross Margin | 11.42% |
| Net Profit Margin | -44.56% |
| Debt/Equity Ratio | 9.4% |
How did AMV perform over the long term?
See historical performance and comparisonDividends
133.3%
Current Dividend Yieldn/a
Payout RatioDoes AMV pay a reliable dividends?
See AMV dividend history and benchmarks| American Vietnamese Biotech Incorporation dividend dates | |
|---|---|
| Ex Dividend Date | Jan 11 2021 |
| Dividend Pay Date | Aug 28 2025 |
| Days until Ex dividend | 1472 days |
| Days until Dividend pay date | 218 days |
Does AMV pay a reliable dividends?
See AMV dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 23:57 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
American Vietnamese Biotech Incorporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|